The purpose of this study is to evaluate the safety and effectiveness of an implantable device to treat migraine. There are a significant number of patients who have drug refractory migraine and alternative therapies are needed.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
11
Implantable Neurostimulator
Royal Free Hospital - Dept of Clinical Neurosciences
London, United Kingdom
Number of Hours of Headache
Time frame: 12 weeks
Number of Days With 4 or More Hours of Headache
Time frame: 12 Weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.